Azacitidine 01
Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 43817-906
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 43817-906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Panacea Biotec Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Azacitidine 02
This appears to be a statistical report on a medical study, with information on survival rates, a Log-Rank test, hazard ratio, and number of deaths in groups labeled "Aza" and "CCR." There is also a chart with time (in months) and number of individuals at risk at different points in time. The meaning and context of the data are not clear from this limited information.*
Azacitidine 03
This is a description of a medication named Azacitidine used for subcutaneous and intravenous use. It comes in a single-dose vial containing 100mg of Azacitidine and 100mg of mannitol as its active and inactive ingredients, respectively. The prescription information should be consulted for proper dosing and administration. The unused portion of the medicine should be discarded, kept out of children's reach, and stored at 25°C (77°F), excursions permitted between 15°-30°C (59°-86°F). The manufacturers are Panacea Biotec Pharma Limited and are distributed by Breckenridge Pharmaceutical, Inc. in Berlin, CT.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
